Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of NHL35700 in adults with schizophrenia
CTR20262175Phase 3Active
- Sponsor
- Jiangsu Nhwa Pharmaceutical
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of NHL35700 in schizophrenia, sponsored by Jiangsu Nhwa Pharmaceutical. Started Jul 2026; status: active.
02
Drugs
NHL35700
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20262175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262175.